Salahudeen Mohammed S, Saadeldean Ahmed Samy, Peterson Gregory M, Tesfaye Behailu Terefe, Curtain Colin M
School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, TAS, Australia.
School of Pharmacy, Faculty of Health Science, Jimma University, Jimma, Ethiopia.
Front Pharmacol. 2025 Mar 26;16:1531500. doi: 10.3389/fphar.2025.1531500. eCollection 2025.
There is limited information regarding community pharmacists' perspectives on implementing a self-administered screening tool for identifying patients at risk of medication-related problems. This study assessed Australian pharmacists' views on introducing such a tool within the community pharmacy setting.
An online cross-sectional survey was conducted among Australian community pharmacists from March to May 2023. The survey collected relevant demographic data and responses on perceived barriers and facilitators to implementing the screening tool. Reliability statistics were computed for the responses on barriers and facilitators, and chi-square or Fisher's Exact tests were performed to assess their association with demographic variables.
Two hundred thirty-one community pharmacists across Australia were surveyed. Most (78%) reported that medication-related problems are common and expressed support for a patient self-administered screening tool to identify patients at high risk of medication-related problems (88%). Over two-thirds (69%) were willing to allocate time for reviewing patient medications if flagged for medication-related problems. The most frequently anticipated barriers to implementing screening tools were time constraints for pharmacists (63%), staff shortage and limited patient interest (each accounting for 57%). In contrast, effective communication with patients (69%) and patients' appreciation of pharmacists' expertise and efforts (67%) were predominantly stated facilitators.
Most community pharmacists were supportive of implementing a patient self-administered screening tool to identify patients at risk of medication-related problems. The study's findings provide valuable insights for developing medication-related problems screening tools tailored to the Australian community pharmacy setting.
关于社区药剂师对实施用于识别有药物相关问题风险患者的自我管理筛查工具的看法,相关信息有限。本研究评估了澳大利亚药剂师对在社区药房环境中引入此类工具的看法。
2023年3月至5月对澳大利亚社区药剂师进行了一项在线横断面调查。该调查收集了相关人口统计学数据以及关于实施筛查工具的感知障碍和促进因素的回复。计算了关于障碍和促进因素回复的可靠性统计数据,并进行卡方检验或费舍尔精确检验以评估它们与人口统计学变量的关联。
对澳大利亚各地的231名社区药剂师进行了调查。大多数(78%)报告称药物相关问题很常见,并表示支持使用患者自我管理的筛查工具来识别有高药物相关问题风险的患者(88%)。超过三分之二(69%)的人愿意在患者被标记有药物相关问题时抽出时间来审查患者的用药情况。实施筛查工具最常预期的障碍是药剂师的时间限制(63%)、人员短缺和患者兴趣有限(各占57%)。相比之下,与患者的有效沟通(69%)和患者对药剂师专业知识和努力的认可(67%)是主要提到的促进因素。
大多数社区药剂师支持实施患者自我管理的筛查工具来识别有药物相关问题风险的患者。该研究结果为开发适合澳大利亚社区药房环境的药物相关问题筛查工具提供了有价值的见解。